New Automated Tool Can Screen for Diabetic Retinopathy
Article ID: 617662
Released: 8-May-2014 11:50 AM EDT
Source Newsroom: Association for Research in Vision and Ophthalmology (ARVO)
Newswise — Orlando, Fla. —Scientists have developed a computer program to screen for diabetic retinopathy, a potentially blinding condition that may affect every person with diabetes. The research is being presented at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week.
EyeArt is a patent-pending, fully automated set of tools able to quickly offer a refer/no-refer recommendation based on images taken of a patient’s retina. Researchers found it to be as accurate as trained specialists in screening for the eye disease.
Diabetic retinopathy, reported as the leading cause of blindness in the adult working-age population, is an eye condition stemming from diabetes that can be successfully treated if diagnosed early. The computerized tool could help increase the number of annual screenings that take place in the primary care setting.
Abstract Title: EyeArt: Advanced Image Analysis Tools for Diabetic Retinopathy Screening and Telemedicine ApplicationsPresentation Start/End Time: Thursday, May 8, 8:30am – 10:15amLocation: Exhibit/Poster Hall SASession Number: 519# # #
The Association for Research in Vision and Ophthalmology (ARVO) is the largest eye and vision research organization in the world. Members include some 12,000 eye and vision researchers from over 70 countries. ARVO encourages and assists research, training, publication and knowledge-sharing in vision and ophthalmology.
All abstracts accepted for presentation at the ARVO Annual Meeting represent previously unpublished data and conclusions. This research may be proprietary or may have been submitted for journal publication. Embargo policy: Journalists must seek approval from the presenter(s) before reporting data from paper or poster presentations. Press releases or stories on information presented at the ARVO Annual Meeting may not be released or published until the conclusion of the presentation.